Does SilverScript Cover Wegovy? Medicare Advantage Coverage Guide 2026
If you’re enrolled in through SilverScript Part D (administered by CVS Health/Aetna) often ask whether their plan covers Wegovy (semaglutide 2.4mg). Here’s the overview: coverage varies by your plan’s formulary tier, Part D structure, and medical indication.
SilverScript’s Formulary Position on Wegovy
SilverScript Part D uses a Part D formulary that tiers medications into cost-sharing tiers. Currently, Wegovy is generally placed on Tier 4 (Non-preferred specialty) on most SilverScript plan designs.
What this means for you:
- Out-of-pocket cost: $100–$300+ depending on your specific plan design
- Prior authorization: Mandatory — a PA request is needed
- Quantity limits: Often enforced — limited to FDA-recommended dosing
- Step therapy: May require failed trial of first-line therapies first
The Medicare Part D coverage gap (donut hole), cost-sharing increases to 25% coinsurance until reaching the catastrophic threshold.
Coverage for FDA-Approved vs. Off-Label Use
For chronic weight management (FDA-approved):
- SilverScript typically will cover Wegovy for on-label use
- Documentation needed: lab work and prescription history
- Coverage is more consistent with proper documentation
For weight loss (for chronic weight management):
- Traditional Medicare does not cover anti-obesity medications under Part D
- However: recent CMS guidance expanded formulary inclusion rules for weight management medications
- SilverScript could provide supplemental benefits that cover weight management medications — call CVS Health/Aetna member services
What You’ll Pay With SilverScript
Calculating your actual cost for Wegovy on SilverScript depends on which Part D coverage phase you’re in.
| Coverage Phase | Estimated Cost |
|---|---|
| Initial Deductible ($590 in 2026) | Full retail price: $1,300–$1,500/month |
| Initial Coverage | 25-33% coinsurance |
| Coverage Gap (Donut Hole) | ~$250–$350/month |
| Catastrophic Coverage | $0 or small copay |
Starting in 2025, out-of-pocket Part D spending is capped at $2,000/year — a major benefit for anyone taking Wegovy.
Tips for Getting Approved
- Ask for a tier exception — If Wegovy is non-preferred, your doctor can request a tier reduction or formulary exception with medical necessity evidence
- Check manufacturer support — Novo Nordisk runs copay cards for eligible Medicare enrollees (government plan restrictions may apply)
- Compare plans during open enrollment — AEP (Oct 15–Dec 7) is your chance to find a better-tier placement
- Apply for Extra Help/LIS — If income-eligible can get Extra Help (Low-Income Subsidy) that significantly reduce out-of-pocket expenses